Logic gate-driven dual-index balanced visualization strategy for tumor metastasis diagnosis
Pengfei Yu1, Weiwei Chen2, Li Ge3
1The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Department of Gastric Surgery, Hangzhou, Zhejiang, 310022, China.
Biosensors & Bioelectronics
|August 3, 2023
Summary
This study introduces a rapid visual kit for distinguishing normal from exfoliated tumor cells in 10 minutes. This diagnostic innovation aids in faster cancer detection and promotes precision medicine.
Area of Science:
- Biomedical diagnostics
- Cytopathology
- Chemical sensing
Background:
- Exfoliated tumor cell detection is crucial for malignant tumor diagnosis.
- Current clinical cytology preparation is time-consuming, often taking over two days.
- There is a need for rapid and accurate methods to screen exfoliated tumor cells.
Purpose of the Study:
- To develop a rapid, visual diagnostic kit for distinguishing normal from exfoliated tumor cells.
- To enable initial screening of exfoliated tumor cells within 10 minutes.
- To integrate advanced algorithms for accurate tumor cell identification.
Main Methods:
- A balanced-etching visual kit utilizing Glutathione/Glucose (GSH/Glu) concentration differences was developed.
- The kit generates color cards for initial visual screening.
- Logic gates and machine learning algorithms were employed for RGB color card analysis.
Main Results:
- The balanced-etching kit successfully distinguished normal from exfoliated tumor cells.
- Initial screening was achieved within 10 minutes.
- Machine learning analysis of color cards provided accurate exfoliated tumor cell screening.
- Validation was performed on various clinical samples including urine, pleural fluids, ascites, and gastric fluids.
Conclusions:
- A novel, rapid diagnostic strategy for exfoliated tumor cells was successfully developed.
- The balanced-etching visual kit offers a fast and accurate method for initial tumor cell screening.
- This approach has the potential to significantly advance precision medicine through improved diagnostic speed and accuracy.


